Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

1,121(a) (a) - (r) See explanatory notes on the following pages. Amgen Inc. Notes to Reconciliation of GAAP Earnings to "Adjusted" Earnings (In millions, except per share data) (Unaudited) (a) To exclude the impact of stock option expense recorded in accordance with Statement of Financial Accounting Standards ("SFAS") No. 123R. For the three and twelve months ended December 31, 2008 and 2007, the total pre-tax expense for employee stock options in accordance with SFAS No. 123R was $26 million and $103 million, respectively, and $41 million and $181 million, respectively. "Adjusted" diluted EPS including the impact of stock option expense for the three and twelve months ended December 31, 2008 and 2007 was as follows: Three months ended Year ended December 31, December 31, ------------ ------------ 2008 2007 2008 2007 ---- ---- ---- ---- "Adjusted" diluted EPS, excluding stock option expense $1.06 $1.00 $4.55 $4.29 Impact of stock option expense (net of tax) (0.02) (0.03) (0.07) (0.12) ----- ----- ----- ----- "Adjusted" diluted EPS, including stock option expense $1.04 $0.97 $4.48 $4.17 ===== ===== ===== ===== (b) To exclude the following restructuring (expenses)/recoveries associated with our restructuring plan announced in August 2007, as follows: Separ- Asset
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... July 24, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... of notice on July 18, 2014 from the ... accepted the CorMedix plan to regain compliance with ... result, the NYSE-MKT is continuing the Company,s listing ...
(Date:7/24/2014)... 24, 2014  Neogen Corporation (Nasdaq: NEOG ... its potential revenue from new rodenticide research are premature. ... analysts on July 22, 2014, Neogen,s CEO commented about ... research. "It was my intent Tuesday at ... of a new type of rodenticide, but certainly not ...
(Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Neogen comments on SenesTech 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... ends the second quarter with more than $535 million in cash ... EDT at ... http://www.isispharm.com , CARLSBAD, Calif., Aug. 7 Isis,Pharmaceuticals, Inc. ... ended June 30, 2008. The Company ended the quarter,in the strongest financial ...
... /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a,company focused ... of diseases and personalized health management, today reported,operational ... year to date,ended June 30, 2008., "The ... blood,test to assess a patient,s current risk of ...
... CHAMPAIGN, Ill. By combining stretchable optoelectronics and ... imaging device, with a layout based on the ... issue of the journal Nature, researchers ... have developed a high-performance, hemispherical "eye" camera using ...
Cached Biology Technology:Isis Reports Financial Results and Highlights for Second Quarter of 2008 2Isis Reports Financial Results and Highlights for Second Quarter of 2008 3Isis Reports Financial Results and Highlights for Second Quarter of 2008 4Isis Reports Financial Results and Highlights for Second Quarter of 2008 5Isis Reports Financial Results and Highlights for Second Quarter of 2008 6Isis Reports Financial Results and Highlights for Second Quarter of 2008 7Isis Reports Financial Results and Highlights for Second Quarter of 2008 8Isis Reports Financial Results and Highlights for Second Quarter of 2008 9Isis Reports Financial Results and Highlights for Second Quarter of 2008 10Isis Reports Financial Results and Highlights for Second Quarter of 2008 11Isis Reports Financial Results and Highlights for Second Quarter of 2008 12Isis Reports Financial Results and Highlights for Second Quarter of 2008 13Isis Reports Financial Results and Highlights for Second Quarter of 2008 14GeneNews Announces Second Quarter Results 2GeneNews Announces Second Quarter Results 3GeneNews Announces Second Quarter Results 4GeneNews Announces Second Quarter Results 5GeneNews Announces Second Quarter Results 6GeneNews Announces Second Quarter Results 7GeneNews Announces Second Quarter Results 8Stretchable silicon camera next step to artificial retina 2
(Date:7/25/2014)... that the age girls reach puberty is influenced by ,imprinted ... parent contributes the gene. This is the first evidence ... birth and details of this study were published today in ... period, known as menarche, is a marker for the timing ... onset of menses varies between girls, is an inherited trait, ...
(Date:7/25/2014)... use of a molecular testing panel developed at ... correct initial surgery for patients with thyroid nodules ... Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter., ... Center and other diagnostic testing agencies, improved the ... by 30 percent, according to the study published ...
(Date:7/25/2014)... Florida , July 25, 2014 ... more consumers are turning to digital technology for online ... (OTCBB: NXTD), Google Inc. (NASDAQ: GOOG ), ... (NYSE: V ), Apple Inc. (NASDAQ: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6
... of scientists has, for the first time, completely characterized an ... ground-level ozone in urban areas. The team,s results indicate that ... during episodes of poor air quality (smoggy days) by as ... poses significant health hazards to people, animals and plants; is ...
... JOLLA, Calif., November 1, 2010 One of the many ... fat, which in turn supports a healthy heart. Fat tissue ... it,s also an active secretory organ that normally produces ... protects the hearts of healthy people has long been a ...
... " Environmental Pollution " details successful experiments at ... in the abiotic (non-biological) transformation and absorption of ... of these estrogen hormones by more than 80 ... implications since it could point to inexpensive treatment ...
Cached Biology News:Study improves accuracy of models for predicting ozone levels in urban areas 2Study improves accuracy of models for predicting ozone levels in urban areas 3Study improves accuracy of models for predicting ozone levels in urban areas 4Study finds fat hormone's long-sought link to heart protection 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 2UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater 3
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Mycoplasma and virus tested...
... Western Protein Standards are specifically designed ... weight estimation directly on western blots. ... binding site, allowing direct visualization with ... detect your target protein on the ...
... Clone/PAD: 3F10B10. Immunogen: ... internal region of JAB1 (Jun ... Specificity: Specific for the ... (positive controls: 293T Jurkat cell ...
Biology Products: